Sjogren’s Syndrome market is anticipated to grow at a CAGR of 4.6% during the forecast period. Sjogren’s syndrome is a disorder of the human immune system whereby it affects the parts of the body that produces fluids such as saliva, tears. It’s a long- term condition that affects one’s daily life and is more common in women than men that usually starts at age 40 to 60. Sjogren also affects the other parts of the body such as kidneys, joints, lungs, nerves, blood vessels. The treatment focuses on relieving the symptoms such as fiving artificial tears for dry eyes, sucking sugar free candies and drinking gallons of water for dry mouth along with taking some medicines. The factors contributing to the market growth include a growing population with several diseases that can cause Sjogren’s syndrome and increasing demand for advanced treatment for Sjogren’s syndrome. Other factors include increased use of contact lens that leads to dryness of eyes, unhealthy lifestyle adoption, increased advanced treatment of eye diseases and growing diseases like rheumatoid arthritis and lupus are propelling the growth of the market.
However, a lack of awareness among the population about Sjogren’s syndrome restrains the growth of the market. Further lack of proper cure treatments is also projected to hamper the growth of the market. Currently, available treatment options are either ineffective in patients with the following syndrome or only relieve the symptoms. Increasing lab automation rates and technological advances will bring upon opportunities for the growth of the market. Additionally, rising government initiatives such as the North American Rheumatoid Arthritis consortium are educating healthcare professionals and patients regarding the diagnosis and its treatment will boost the growth of the Sjogren’s syndrome market.
To Request a Sample of our Report on Global Sjogren’s Syndrome Acids Market: https://www.omrglobal.com/request-sample/sjogrens-syndrome-acids-market
Sjogren’s Syndrome Market Segmentation
By Drug Type
- Pilocarpine
- Cyclosporine
- Hydroxychloroquine
- Immunosuppressive Agents
By Type
- Primary Sjögren’s Syndrome
- Secondary Sjögren’s Syndrome
A full Report of Global Sjogren’s Syndrome Acids Market is Available @ https://www.omrglobal.com/industry-reports/sjogrens-syndrome-acids-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- AbbVie Inc.
- Amgen Inc.
- Argentis Pharmaceuticals, LLC
- AstraZeneca PLC
- Aldeyra Therapeutics, Inc.
- Bristol-Myers Squibb Co.
- Biogen Inc.
- Demcon Hemics BV.
- Daiichi Sankyo Co., Ltd.
- Eisai Co., Ltd.
- Hoffmann-La Roche Ltd.
- Horizon Therapeutics Plc
- Novartis AG
- Otsuka Pharmaceutical Co., Ltd.
- ONO PHARMACEUTICAL CO., LTD
- Pfizer Inc.
- Sanofi S.A.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/sjogrens-syndrome-acids-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
